This section is provided for qualified healthcare practitioners as professional education. It summarises selected ingredient-level research. It does not represent additional ARTG indications for Blue 1 — Blueberin.
Vaccinium myrtilloides and antioxidant research
Vaccinium myrtilloides leaf extract has been discussed in professional literature in relation to antioxidant activity and free radical research.
This information is provided as practitioner education only and should not be interpreted as a claim that Blue 1 — Blueberin treats or manages blood glucose, diabetes, cholesterol, obesity, cardiovascular disease, liver enzymes, inflammation, arterial plaque or any other disease condition.
Ingredient research highlights
Vaccinium myrtilloides
A botanical ingredient discussed in literature relating to antioxidant activity, oxidative stress pathways and free radical research.
The above information is provided to support professional understanding of the ingredient and antioxidant pathways. It should not be used to promote Blue 1 — Blueberin for hyperlipidaemia, high blood glucose, diabetes, obesity, cardiovascular disease, atherosclerosis, liver enzyme reduction or any indication not included in the ARTG entry.
References available to registered practitioners on request.
